LABORATORY CORPORATION OF AMERICA HOLDINGS Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 201.5 USD | -0.01% |
|
+0.23% | -11.22% |
Presenter SpeechHima Inguva (Executives)Good morning, everyone. I am Hima Inguva, Head of Inve...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows:
- clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services;
- development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies.
Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
2024-05-14
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
201.5
USD
Average target price
239.6
USD
Spread / Average Target
+18.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.22% | 16.99B | |
| +14.68% | 82.36B | |
| -30.33% | 69.97B | |
| +10.99% | 29.41B | |
| +1.21% | 17.08B | |
| -0.53% | 15.21B | |
| +3.55% | 13.25B | |
| +63.00% | 12.12B | |
| +30.26% | 12.08B | |
| +55.46% | 11.88B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Transcript : Laboratory Corporation of America Holdings - Analyst/Investor Day